Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec:84:53-56.
doi: 10.1016/j.ijsu.2020.10.018. Epub 2020 Oct 23.

Ebselen, a new candidate therapeutic against SARS-CoV-2

C V Haritha  1 , Khan Sharun  2 , Bosco Jose  3
Affiliations
Comment

Ebselen, a new candidate therapeutic against SARS-CoV-2

C V Haritha et al. Int J Surg. 2020 Dec.
No abstract available

Keywords: COVID-19; Clinical trials; Ebselen; Main protease; Repurposed drug; SARS-CoV-2; Therapeutics.

PubMed Disclaimer

Conflict of interest statement

All authors declare that there exist no commercial or financial relationships that could, in any way, lead to a potential conflict of interest.

Figures

Fig. 1
Fig. 1
Chemical structure of ebselen, an organoselenium compound that mimics glutathione peroxidase activity.
Fig. 2
Fig. 2
Ebselen exhibits antiviral activity against SARS-CoV-2 via the inhibition of the main viral protease (Mpro).
See this image and copyright information in PMC

Comment on

References

    1. Abbasi-Oshaghi E., Mirzaei F., Farahani F., Khodadadi I., Tayebinia H. Diagnosis and treatment of coronavirus disease 2019 (COVID-19): laboratory, PCR, and chest CT imaging findings. Int. J. Surg. 2020 Jul;79:143–153. doi: 10.1016/j.ijsu.2020.05.018. - DOI - PMC - PubMed
    1. Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C., Duan Y., Yu J., Wang L., Yang K., Liu F., Jiang R., Yang X., You T., Liu X., Yang X., Bai F., Liu H., Liu X., Guddat L.W., Xu W., Xiao G., Qin C., Shi Z., Jiang H., Rao Z., Yang H. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020 Jun;582(7811):289–293. doi: 10.1038/s41586-020-2223-y. - DOI - PubMed
    1. Sies H., Parnham M.J. Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections. Free Radic. Biol. Med. 2020 Aug 20;156:107–112. doi: 10.1016/j.freeradbiomed.2020.06.032. - DOI - PMC - PubMed
    1. Zhang D.W., Yan H.L., Xu X.S., Xu L., Yin Z.H., Chang S., Luo H. The selenium-containing drug ebselen potently disrupts LEDGF/p75-HIV-1 integrase interaction by targeting LEDGF/p75. J. Enzym. Inhib. Med. Chem. 2020 Dec;35(1):906–912. doi: 10.1080/14756366.2020.1743282. - DOI - PMC - PubMed
    1. Mukherjee S., Weiner W.S., Schroeder C.E., Simpson D.S., Hanson A.M., Sweeney N.L., Marvin R.K., Ndjomou J., Kolli R., Isailovic D., Schoenen F.J., Frick D.N. Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication. ACS Chem. Biol. 2014 Oct 17;9(10):2393–2403. doi: 10.1021/cb500512z. - DOI - PMC - PubMed